SCHEMBL22690989

SCHEMBL22690989

O=C(O)N[C@H](CCO)c1cccc(Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
ROCK1 Q13464 4/20 0.42
PRKACA P17612 1/20 0.42
CDK8 P49336 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
PRKX P51817 1/20 0.42
PRKCQ Q04759 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
CYP26A1 O43174 1/20 0.42
ROCK2 O75116 3/20 0.41
TACR3 P29371 1/20 0.41
CTSA P10619 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PHGDH O43175 1/20 0.39
CDC42BPA Q5VT25 1/20 0.38
SLC6A9 P48067 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16396919 1.00 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTHTTROCK1
SCHEMBL16396348 0.88 ALDH1A1 (0.46) ALDH1A1NPSR1MAPTHTTROCK1
SCHEMBL18765605 0.88 ALDH1A1 (0.46) ALDH1A1NPSR1MAPTHTTROCK1
SCHEMBL22691484 0.87 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTHTTCYP26A1
SCHEMBL22691487 0.87 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTHTTCYP26A1
SCHEMBL16396920 0.87 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTHTTCYP26A1
SCHEMBL22690845 0.85 ALDH1A1 (0.42) ALDH1A1NPSR1MAPTHTTCYP26A1
SCHEMBL14142694 0.83 ALDH1A1 (0.59) ALDH1A1NPSR1MAPTHTTCYP26A1
SCHEMBL14691111 0.83 PHGDH (0.50) ALDH1A1ROCK1PRKACACDK8GSK3A
SCHEMBL16397066 0.83 ALDH1A1 (0.44) ALDH1A1NPSR1MAPTHTTCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3972590-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES Merck Sharp & Dohme Corp. (US) 2022-03-30 EP disclosed
WO-2020236688-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES MERCK SHARP & DOHME CORP. (US) 2020-11-26 WO disclosed